As a proof of concept, a previous study showed that inhibition of caveolin-1 signalling by siRNA or caveolin scaffolding peptide in inflammatory breast cancer cells resulted in a reduction in invasive potential in an Akt1-dependent manner [46]. This evidence concerns the gene CAV1 and breast cancer.